| Application no. and date | 10178998.0 (espacenet) (Federated) (European Patent Register), 20051207 | | Patent/reg. no. and date | DK/EP 2260835, 20130306 | | Publication date | 20101215 | | Priority no. and date | US 634366 P, 20041207, US 634366, 20041207, US 655930 P, 20050223, US 655930, 20050223 | | EP pub. no. and date |
EP 2260835 20101215 | | Effective date | | | Applicant/owner | Onyx Therapeutics, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | P006017EPDK2 EJ/GB | | Inventor | LEWIS, Evan R., 631 Miller Avenue
Pacifica, CA 94044, US,
HO, Mark Nguyen, 3330 Shoshana Lane
San Jose, CA 95135, US,
FONSECA, Fabiana N., 30 River Road,
Apt. 8g
New York, NY 10044, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/336 (2006.01) , A61K 31/396 (2006.01) , A61K 47/40 (2006.01) , A61K 9/00 (2006.01) , A61K 9/19 (2006.01) | | Title | Sammensætning til proteasominhibering | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
